ASX:BKL Blackmores (BKL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Blackmores Stock (ASX:BKL) 30 days 90 days 365 days Advanced Chart Get Blackmores alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume75,759 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield1.84%Price TargetN/AConsensus RatingN/A Company OverviewBlackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and India. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; everyday health; and eye health. In addition, the company offers products in the areas of fish and nutritional oils; heart and circulation; infant nutrition; kids health; men's health; multivitamins; nails, hair, and skin; pet health; probiotics; pregnancy and preconception; stress relief and sleep support; weight management; wellbeing management; and women's health. It provides its products through retail and online channels. The company was founded in 1930 and is headquartered in Sydney, Australia.Read More… Receive BKL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Blackmores and its competitors with MarketBeat's FREE daily newsletter. Email Address BKL Stock News HeadlinesThe Ethical Investor: Here are the ASX companies backing biodiversity movement, ‘Nature Positive Matters’November 8, 2024 | msn.comThings you may not know about Made in Australia, and ASX stocks that manufacture right hereApril 22, 2024 | msn.comDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. January 22, 2025 | Crypto 101 Media (Ad)Clover Corp Ltd UWAFebruary 29, 2024 | morningstar.comDividend Investors: Don't Be Too Quick To Buy Blackmores Limited (ASX:BKL) For Its Upcoming DividendJuly 22, 2023 | finance.yahoo.comBlackmores takeover is official: Here’s when to expect the cash for your sharesJuly 20, 2023 | fool.com.auThis ASX 200 stock just announced a special dividend. Here’s the lowdownJuly 12, 2023 | fool.com.auBlackmores $1.9b buyout price is ‘fair and reasonable’: expertJune 8, 2023 | afr.comSee More Headlines BKL Stock Analysis - Frequently Asked Questions How were Blackmores' earnings last quarter? Blackmores Limited (ASX:BKL) released its quarterly earnings results on Tuesday, February, 19th. The company reported $1.99 earnings per share for the quarter, missing the consensus estimate of $2.18 by $0.19. Blackmores had a trailing twelve-month return on equity of 9.36% and a net margin of 5.36%. What other stocks do shareholders of Blackmores own? Based on aggregate information from My MarketBeat watchlists, some other companies that Blackmores investors own include Citizens (CIA), Bonavista Energy Co. (BNP.TO) (BNP), Altium (ALU), OncoSil Medical (OSL), Pinnacle West Capital (PNW), Select Harvests (SHV) and ECN Capital (ECN). Company Calendar Last Earnings2/19/2019Today1/22/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorConsumer Defensive Industry Packaged Foods Sub-IndustryN/A Current SymbolASX:BKL CUSIPN/A CIKN/A Webwww.blackmores.com.au Phone+61-2-99105000FaxN/AEmployees1,200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$1.76 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.31Net Income$34.61 million Net Margins5.36% Pretax MarginN/A Return on Equity9.36% Return on Assets5.84% Debt Debt-to-Equity Ratio5.07 Current Ratio2.61 Quick Ratio1.27 Sales & Book Value Annual Sales$645 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow39.12 Book ValueA$21.55 per share Price / BookN/AMiscellaneous Outstanding Shares19,450,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.61 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report This page (ASX:BKL) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blackmores Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Blackmores With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.